phenylalanine has been researched along with Recrudescence in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aschan, J; Pour, L; Robak, P; Schjesvold, F; Sonneveld, P | 1 |
| Gullbo, J; Hajek, R; Hassoun, H; Larocca, A; Leleu, X; Oriol, A; Paner, A; Richardson, PG; Rodríguez-Otero, P; Schjesvold, FH | 1 |
| Alegre, A; Anderson, KC; Bakker, NA; Bladé, J; Byrne, C; Cavo, M; Harmenberg, J; Hassoun, H; Hiemenz, JW; Larocca, A; Laubach, JP; Leleu, X; Maisel, C; Mateos, MV; Mazumder, A; Moreb, JS; Nadeem, O; Oriol, A; Paner, A; Raptis, A; Richardson, PG; Rodriguez-Otero, P; Thuresson, M; Thuresson, S; Touzeau, C | 1 |
| Dayanath, BKTP; Dayasiri, KC; Jasinge, E; Nawarathne, D; Senanayake, UE; Suraweera, N; Weerasekara, K | 1 |
| Bennett, B; Cnops, J; Morris, DL; Otoul, C; Sidhu, J; Taubel, J; Wolf, C | 1 |
| Wang, M; Xiao, L | 1 |
| Cannizzaro, C; De Caro, V; Giannola, LI; Lavanco, G; Plescia, F; Sutera, FM | 1 |
| Dal Cin, P; Hernandez, JM; Kuo, FC; Leon, A; Longtine, JA; Staropoli, JF | 1 |
| Choi, JR; Kim, J; Kim, Y; Lee, KA; Lyu, CJ; Shin, S | 1 |
| Au, WY; Fung, A; Kwong, YL; Lam, CC; Lam, KY; Lie, AK | 1 |
| Beelen, DW; Ditschkowski, M; Elmaagacli, AH; Koldehoff, M; Steckel, NK | 1 |
| Steensma, DP; Tefferi, A | 1 |
| Morimoto, K; Shido, F | 1 |
| Hara, K; Horigome, T; Kobayashi, T; Sugita, N; Van De Winkel, JG; Van Der Pol, W; Yamamoto, K; Yoshie, H | 1 |
| Ernst, R; Löffler, A; Miederer, SE; Stadelmann, O | 1 |
1 review(s) available for phenylalanine and Recrudescence
| Article | Year |
|---|---|
Melflufen for relapsed and refractory multiple myeloma.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Humans; Melphalan; Multiple Myeloma; Phenylalanine; Recurrence; Survival Rate | 2020 |
3 trial(s) available for phenylalanine and Recrudescence
| Article | Year |
|---|---|
OCEAN: a randomized Phase III study of melflufen + dexamethasone to treat relapsed refractory multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Dexamethasone; Drug Resistance, Neoplasm; Humans; Lenalidomide; Melphalan; Multiple Myeloma; Phenylalanine; Progression-Free Survival; Randomized Controlled Trials as Topic; Recurrence; Thalidomide | 2020 |
Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Disease Progression; Drug Resistance, Neoplasm; Europe; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Phenylalanine; Progression-Free Survival; Recurrence; Time Factors; United States | 2021 |
Pharmacodynamic consequences of administration of VLA-4 antagonist CDP323 to multiple sclerosis subjects: a randomized, double-blind phase 1/2 study.
Topics: Adult; Double-Blind Method; Drug Administration Schedule; Female; Flow Cytometry; Humans; Integrin alpha4; Integrin alpha4beta1; Lymphocytes; Male; Middle Aged; Multiple Sclerosis; Naphthyridines; Phenylalanine; Recurrence; Treatment Outcome; Vascular Cell Adhesion Molecule-1 | 2013 |
11 other study(ies) available for phenylalanine and Recrudescence
| Article | Year |
|---|---|
GTP-Cyclohydrolase I deficiency presenting as malignant hyperphenylalaninemia, recurrent hyperthermia and progressive neurological dysfunction in a South Asian child - a case report.
Topics: Brain; Consanguinity; Fever; GTP Cyclohydrolase; Humans; Infant; Male; Nervous System Diseases; Phenylalanine; Phenylketonurias; Recurrence; Sri Lanka; Vomiting | 2019 |
Batimastat nanoparticles associated with transcatheter arterial chemoembolization decrease hepatocellular carcinoma recurrence.
Topics: Carcinoma, Hepatocellular; Catheters; Chemoembolization, Therapeutic; Combined Modality Therapy; Humans; Liver Neoplasms; Nanoparticles; Phenylalanine; Recurrence; Thiophenes | 2014 |
Effects of DA-Phen, a dopamine-aminoacidic conjugate, on alcohol intake and forced abstinence.
Topics: Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Anxiety; Central Nervous System Depressants; Conditioning, Operant; Disease Models, Animal; Dopamine; Dopamine Agents; Drug-Seeking Behavior; Ethanol; Male; Phenylalanine; Rats, Wistar; Recurrence; Self Administration | 2016 |
Translocation t(1;9) is a recurrent cytogenetic abnormality associated with progression of essential thrombocythemia patients displaying the JAK2 V617F mutation.
Topics: Aged; Aged, 80 and over; Amino Acid Substitution; Chromosome Aberrations; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 9; Cohort Studies; Disease Progression; Female; Humans; Janus Kinase 2; Male; Middle Aged; Mutation, Missense; Phenylalanine; Recurrence; Thrombocythemia, Essential; Translocation, Genetic; Valine | 2011 |
A novel F11 mutation in a Korean pediatric patient with recurrent epistaxis.
Topics: Amino Acid Sequence; Animals; Asian People; Base Sequence; Child; Epistaxis; Factor XI; Factor XI Deficiency; Heterozygote; Humans; Leucine; Male; Molecular Sequence Data; Mutation; Pedigree; Phenylalanine; Recurrence; Sequence Alignment | 2013 |
Reemergence of JAK2 V617F clone heralds extramedullary leukemia relapse after BMT for transformed essential thrombocytosis.
Topics: Bone Marrow Transplantation; Graft vs Host Disease; Humans; Janus Kinase 2; Leukemia; Male; Middle Aged; Mutation; Phenylalanine; Recurrence; Thrombocythemia, Essential; Treatment Failure; Valine | 2007 |
Use of the activating gene mutation of the tyrosine kinase (VAL617Phe) JAK2 as a minimal residual disease marker in patients with myelofibrosis and myeloid metaplasia after allogeneic stem cell transplantation.
Topics: Adult; Biomarkers; Computer Systems; Feasibility Studies; Female; Follow-Up Studies; Gene Expression Regulation; Humans; Janus Kinase 2; Male; Middle Aged; Mutation; Phenylalanine; Polymerase Chain Reaction; Primary Myelofibrosis; Recurrence; Retrospective Studies; Stem Cell Transplantation; Transplantation Chimera; Transplantation, Homologous; Valine | 2007 |
JAK2 V617F and ringed sideroblasts: not necessarily RARS-T.
Topics: Anemia, Sideroblastic; Humans; Janus Kinase 2; Phenylalanine; Recurrence; Thrombocytosis; Valine | 2008 |
Amino acid transport in human tonsillar lymphocytes with regard to patient's age and tonsillar diseases.
Topics: Adult; Age Factors; Alanine; Amino Acids; Arthritis, Rheumatoid; B-Lymphocytes; Biological Transport; Child; Child, Preschool; Glutamine; Humans; Lymphocytes; Lysine; Palatine Tonsil; Phenylalanine; Recurrence; Serine; T-Lymphocytes; Tonsillitis | 1984 |
Relevance of Fc gamma RIIIa-158V-F polymorphism to recurrence of adult periodontitis in Japanese patients.
Topics: Adult; Age Factors; Aged; Alleles; Amino Acid Substitution; Female; Genotype; Humans; Male; Middle Aged; Periodontitis; Phenylalanine; Polymorphism, Genetic; Receptors, IgG; Recurrence; Valine | 1999 |
[Determination of chymotrypsin in the stool by succinyl-L-phenylalanin-P-nitraniliden (Suphepa) in the diagnosis of pancreatic diseases (author's transl)].
Topics: Acute Disease; Anilides; Cholecystokinin; Chronic Disease; Chymotrypsin; Diagnosis, Differential; Duodenum; Evaluation Studies as Topic; False Negative Reactions; False Positive Reactions; Feces; Humans; Indicators and Reagents; Intestinal Secretions; Pancreatic Diseases; Phenylalanine; Recurrence; Secretin | 1975 |